Best Practice & Research Clinical Gastroenterology · Oct 2026
GERD AND OBESITY
By Scarpellini E, Tack J
Background Gastroesophageal reflux disease (GERD) is a gastrointestinal disorder associated with an increased risk of esophagitis, esophageal strictures, Barrett esophagus and esophageal adenocarcinoma. According to several epidemiological studies excess obesity and central visceral adiposity can be risk factors for GERD. Methods We performed a narrative review of literature evidence on the nutritional approach to dumping syndrome. In detail, we made a search on main medical databases for publications using the following keywords, their acronyms and their associations (e.g., “and “): “obesity”,” GERD”, “ Barrett esophagus “, “ esophageal adenocarcinoma “, “ bariatric surgery”, “glucagon like peptides agonists”. Results Obesity and, more specifically central adiposity are risk factors for GERD and its complications. Novel incretin drugs’ use can be associated, especially in the short period, with GERD. Reflux surgery and, also bariatric surgery can be associated at various degree with GERD and its complications’ occurrence/recurrence in obese subjects. A personalized GERD treatment flow-chart is proposed for its management in obese patients. Conclusions obesity and central adiposity are associated with GERD. Pharmacological and surgical treatment for obesity and, also anti-reflux surgery for GERD, can be associated with reflux occurrence/recurrence.